Uterine Fibroid Stocks List

Uterine Fibroid Stocks Recent News

Date Stock Title
May 2 NBIX Neurocrine Biosciences Inc (NBIX) Q1 2024 Earnings: Strong Revenue Growth and Strategic Advancements
May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
May 1 NBIX Neurocrine Q1 revenue beats Street, gets FDA okay for Ingrezza Sprinkle
May 1 NBIX Neurocrine Biosciences, Inc. (NBIX) Q1 2024 Earnings Call Transcript
May 1 NBIX Why Things Are Looking Up For IBD Stock Of The Day Neurocrine, A Top 1% Biotech
May 1 NBIX Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say
May 1 NBIX Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
May 1 NBIX Neurocrine Biosciences Non-GAAP EPS of $1.20 misses by $0.09, revenue of $515.3M beats by $3.29M
May 1 NBIX Neurocrine Biosciences Reports First Quarter 2024 Financial Results
Apr 30 NBIX UPDATE 2-Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Apr 30 NBIX Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
Apr 30 NBIX Neurocrine Biosciences Q1 2024 Earnings Preview
Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
Apr 30 NBIX Curious about Neurocrine (NBIX) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Apr 29 ABBV AbbVie: The Inevitable Is Happening
Apr 29 ABBV Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
Uterine Fibroid

Uterine fibroids, also known as uterine leiomyomas or fibroids, are benign smooth muscle tumors of the uterus. Most women have no symptoms while others may have painful or heavy periods. If large enough, they may push on the bladder causing a frequent need to urinate. They may also cause pain during sex or lower back pain. A woman can have one uterine fibroid or many. Occasionally, fibroids may make it difficult to become pregnant, although this is uncommon.The exact cause of uterine fibroids is unclear. However, fibroids run in families and appear to be partly determined by hormone levels. Risk factors include obesity and eating red meat. Diagnosis can be performed by pelvic examination or medical imaging.Treatment is typically not needed if there are no symptoms. NSAIDs, such as ibuprofen, may help with pain and bleeding while paracetamol (acetaminophen) may help with pain. Iron supplements may be needed in those with heavy periods. Medications of the gonadotropin-releasing hormone agonist class may decrease the size of the fibroids but are expensive and associated with side effects. If greater symptoms are present, surgery to remove the fibroid or uterus may help. Uterine artery embolization may also help. Cancerous versions of fibroids are very rare and are known as leiomyosarcomas. They do not appear to develop from benign fibroids.About 20% to 80% of women develop fibroids by the age of 50. In 2013, it was estimated that 171 million women were affected worldwide. They are typically found during the middle and later reproductive years. After menopause, they usually decrease in size. In the United States, uterine fibroids are a common reason for surgical removal of the uterus.

Browse All Tags